keyword
https://read.qxmd.com/read/38569707/global-trends-in-chronic-kidney-disease-related-mortality-a-systematic-review-protocol
#21
JOURNAL ARTICLE
Somkanya Tungsanga, Anukul Ghimire, Vinash K Hariramani, Abdullah Abdulrahman, Ana S Khan, Feng Ye, Janice Y Kung, Scott Klarenbach, Stephanie Thompson, David Collister, Nattachai Srisawat, Ikechi G Okpechi, Aminu K Bello
INTRODUCTION: In recent decades, all-cause mortality has increased among individuals with chronic kidney disease (CKD), influenced by factors such as aetiology, standards of care and access to kidney replacement therapies (dialysis and transplantation). The recent COVID-19 pandemic also affected mortality over the past few years. Here, we outline the protocol for a systematic review to investigate global temporal trends in all-cause mortality among patients with CKD at any stage from 1990 to current...
April 3, 2024: BMJ Open
https://read.qxmd.com/read/38569690/rehabilitation-interventions-to-modify-physical-frailty-in-adults-before-lung-transplantation-a-systematic-review-protocol
#22
JOURNAL ARTICLE
Laura McGarrigle, Gill Norman, Helen Hurst, Chris Todd
INTRODUCTION: Lung transplantation is the gold-standard treatment for end-stage lung disease for a small group of patients meeting strict acceptance criteria after optimal medical management has failed. Physical frailty is prevalent in lung transplant candidates and has been linked to worse outcomes both on the waiting list and postoperatively. Exercise has been proven to be beneficial in optimising exercise capacity and quality of life in lung transplant candidates, but its impact on physical frailty is unknown...
April 3, 2024: BMJ Open
https://read.qxmd.com/read/38567606/the-crispr-cas9-induced-ccr5-%C3%AE-32-mutation-as-a-potent-gene-therapy-methodology-for-resistance-to-hiv-1-variant-a-review
#23
REVIEW
M Saifullah, O Laghzaoui, H Ozyahyalar, A Irfan
Human Immunodeficiency Virus (HIV) has continuously been the greatest epidemic for humanity over a period spanning almost five decades. With no specific cure or treatment available to date despite extensive research, the C-C Chemokine Receptor 5, Delta 32 (CCR5 Δ32) allele genetic point mutation plays an imperative role in the prevention of acquired immunodeficiency syndrome (AIDS). This comprehensive study aims to review the induction of the homozygous recessive deletion genotype using the Clustered Regularly Interspaced Short Palindromic Repeats, Cas 9 Enzyme (CRISPR-Cas9), and hematopoietic stem cell transplantation under positive selection pressure for active immunity in seropositive patients' populations as the phenotype...
March 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38567255/revolutionizing-stroke-recovery-unveiling-the-promise-of-stem-cell-therapy
#24
REVIEW
Leonidas D Panos, Panagiotis Bargiotas, Marcel Arnold, Georgios Hadjigeorgiou, Georgios D Panos
Stem cells, renowned for their unique regenerative capabilities, present significant hope in treating stroke, a major cause of disability globally. This review offers a detailed analysis of stem cell applications in stroke (ischemic and hemorrhagic) recovery. It examines therapies based on autologous (patient-derived), allogeneic (donor-derived), and Granulocyte-Colony Stimulating Factor (G-CSF) based stem cells, focusing on cell types such as Mesenchymal Stem/Stromal Cells (MSCs), Bone Marrow Mononuclear Stem Cells (BMMSCs), and Neural Stem/Progenitor Cells (NSCs)...
2024: Drug Design, Development and Therapy
https://read.qxmd.com/read/38558788/targeted-drug-delivery-of-engineered-mesenchymal-stem-stromal-cell-derived-exosomes-in-cardiovascular-disease-recent-trends-and-future-perspectives
#25
REVIEW
Jian-Liang Pang, Hong Shao, Xiao-Gang Xu, Zhi-Wei Lin, Xiao-Yi Chen, Jin-Yang Chen, Xiao-Zhou Mou, Pei-Yang Hu
In recent years, stem cells and their secretomes, notably exosomes, have received considerable attention in biomedical applications. Exosomes are cellular secretomes used for intercellular communication. They perform the function of intercellular messengers by facilitating the transport of proteins, lipids, nucleic acids, and therapeutic substances. Their biocompatibility, minimal immunogenicity, targetability, stability, and engineerable characteristics have additionally led to their application as drug delivery vehicles...
2024: Frontiers in Bioengineering and Biotechnology
https://read.qxmd.com/read/38557980/biliary-atresia-in-uganda-current-ethical-challenges-and-advancement-of-public-policy
#26
JOURNAL ARTICLE
Nasser Kakembo, J Isaac Loy, Tamara N Fitzgerald, Ryan M Antiel
Biliary atresia is a progressive cholangiopathy in neonates, which often results in liver failure. In high-income countries, initial treatment requires prompt diagnosis followed by Kasai portoenterostomy. For those with a late diagnosis, or those in whom Kasai portoenterostomy fails, liver transplantation is the only lifesaving treatment. Unfortunately, in low- and middle-income countries, timely diagnosis is a challenge and liver transplantation is rarely accessible. Here, we discuss the ethical dilemmas surrounding treatment of babies with biliary atresia in Uganda...
April 1, 2024: World Journal of Surgery
https://read.qxmd.com/read/38553074/protocol-for-a-mixed-methods-study-to-develop-and-feasibility-test-a-digital-system-for-the-capture-of-patient-reported-outcomes-pros-in-patients-receiving-chimeric-antigen-receptor-t-cell-car-t-therapies-the-pro-car-t-study
#27
JOURNAL ARTICLE
Sarah E Hughes, Christel McMullan, Olalekan Lee Aiyegbusi, Karen Shaw, Francesca Kinsella, Paul Ferguson, Foram Khatsuria, David Burns, Lester Pyatt, John Ansell, Evelyn Chakera, Julie Richardson-Abraham, Alastair K Denniston, Elin Haf Davies, Charles Craddock, Melanie Calvert
INTRODUCTION: Chimeric antigen receptor (CAR) T-cell therapies are novel, potentially curative therapies for haematological malignancies. CAR T-cell therapies are associated with severe toxicities, meaning patients require monitoring during acute and postacute treatment phases. Electronic patient-reported outcomes (ePROs), self-reports of health status provided via online questionnaires, can complement clinician observation with potential to improve patient outcomes. This study will develop and evaluate feasibility of a new ePRO system for CAR-T patients in routine care...
March 29, 2024: BMJ Open
https://read.qxmd.com/read/38553062/tripartite-prehabilitation-of-patients-with-acute-myeloid-leukaemia-and-high-risk-myelodysplastic-syndromes-during-intensive-chemotherapy-before-allogeneic-haematopoietic-stem-cell-transplantation-cohabilit-protocol-for-an-innovating-prospective-multicentre
#28
JOURNAL ARTICLE
Colombe Saillard, Sarah Cuvelier, Charlène Villaron-Goetgheluck, Jean-Marie Boher, Leonor Almeida-Lopez, Anne-Gaelle Le Corroller, Pauline Denis, Céline Rivieccio, Sarah Calvin, Norbert Vey, Cécile Bannier-Braticevic
OBJECTIVES: Acute myeloid leukaemia (AML) and high-risk myelodysplastic syndromes (MDS) are often treated with intensive chemotherapy followed by allogeneic haematopoietic stem cell transplantation (allo-HSCT). The pretransplant treatment results in a general deterioration of the patient's health and quality of life. Furthermore, allo-HSCT can be responsible for significant toxicity with risks of graft-versus-host disease (GvHD). Developing strategies to prevent physical deconditioning, undernutrition and psychological distress could help maintain a satisfactory general state of health before transplantation and thus limit these deleterious effects...
March 29, 2024: BMJ Open
https://read.qxmd.com/read/38549233/a-study-protocol-for-live-and-deceased-donor-uterus-transplantation-as-a-treatment-for-women-with-uterine-factor-infertility
#29
JOURNAL ARTICLE
Jana Pittman, Mats Brännström, Neill Keily, Brigitte Gerstl, Elena Cavazzoni, Henry Pleass, Mianna Lotz, Natasha Rogers, Germaine Wong, Wayne Hsueh, Ashraf Hanafy, Jason A Abbott, Rebecca Deans
AIM: Uterus transplantation (UTx) is an emerging treatment option for women with uterine factor infertility (UFI) or the absence of a functional uterus. This is the study protocol for the first human UTx clinical trial in Australia. MATERIALS AND METHODS: This protocol outlines the approved training program used to plan, diagnose, screen, and treat patients who may be eligible for UTx using living and deceased donors. This multi-site clinical research study includes three tertiary hospital sites within New South Wales (NSW), Australia - Prince of Wales, Royal Hospital for Women and Westmead Hospitals...
March 28, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38541138/evolution-of-liver-transplantation-indications-expanding-horizons
#30
REVIEW
Sara Battistella, Marco Grasso, Elisa Catanzaro, Francesca D'Arcangelo, Giorgia Corrà, Giacomo Germani, Marco Senzolo, Alberto Zanetto, Alberto Ferrarese, Martina Gambato, Patrizia Burra, Francesco Paolo Russo
Liver transplantation (LT) has significantly transformed the prognosis of patients with end-stage liver disease and hepatocellular carcinoma (HCC). The traditional epidemiology of liver diseases has undergone a remarkable shift in indications for LT, marked by a decline in viral hepatitis and an increase in metabolic dysfunction-associated steatotic liver disease (MASLD), along with expanded indications for HCC. Recent advancements in surgical techniques, organ preservation and post-transplant patients' management have opened new possibilities for LT...
February 28, 2024: Medicina
https://read.qxmd.com/read/38538063/is-it-ethically-permissible-for-gps-to-promote-non-directed-altruistic-kidney-donation-to-healthy-adults
#31
JOURNAL ARTICLE
Richard Armitage
Doctors hold coexisting ethical duties to avoid causing deliberate harm to their patients (non-maleficence), to act in patients' best interests (beneficence), to respect patients' right to self-determination (autonomy) and to ensure that costs and benefits are fairly distributed among patients (justice). In the context of non-directed altruistic kidney donations (NDAKD), doctors' duties of autonomy and justice are in tension with those of non-maleficence and beneficence. This article examines these competing duties across three scenarios in which general practitioners (GPs) could promote NDAKD to healthy adults...
March 27, 2024: Journal of Medical Ethics
https://read.qxmd.com/read/38530655/the-altruism-requirement-as-moral-fiction
#32
JOURNAL ARTICLE
Luke Semrau
It is widely agreed that living kidney donation is permitted but living kidney sales are not. Call this the Received View. One way to support the Received View is to appeal to a particular understanding of the conditions under which living kidney transplantation is permissible. It is often claimed that donors must act altruistically, without the expectation of payment and for the sake of another. Call this the Altruism Requirement. On the conventional interpretation, the Altruism Requirement is a moral fact...
March 26, 2024: Journal of Medicine and Philosophy
https://read.qxmd.com/read/38524000/diagnostic-accuracy-of-narrow-band-imaging-in-predicting-helicobacter-pylori-gastritis-in-patients-with-dyspepsia
#33
JOURNAL ARTICLE
Hassan Liaquat Memon, Raja Taha Yaseen, Muhammad Ali Khalid, Ghulamullah Lail, Saleem Shahzad, Muhammad Manzoor Ul Haque, Ghazi Abrar, Shoaib Ahmed Khan, Syed Mudassir Laeeq, Nasir Hassan Luck
Background Helicobacter pylori ( H. pylori ) is one of the most prevalent causes of chronic gastritis that can lead to gastric cancer if left untreated. Currently, endoscopy and histology are the gold standard tests for the diagnosis of H. pylori gastritis. Recently, studies have shown the utility of narrow-band imaging (NBI) in predicting H. pylori gastritis. Therefore, we aimed to determine the diagnostic accuracy of NBI in predicting H. pylori gastritis in patients with dyspepsia. Methodology After obtaining approval from the Ethical Review Committee, Sindh Institute of Urology and Transplantation, this cross-sectional study was conducted in the outpatient Clinic of Hepatogastroenterology of the institute...
February 2024: Curēus
https://read.qxmd.com/read/38519049/study-protocol-for-a-randomised-controlled-trial-of-early-transjugular-intrahepatic-portosystemic-stent-shunt-in-acute-variceal-bleeding-react-avb-trial
#34
JOURNAL ARTICLE
Dhiraj Tripathi, David Patch, Homoyon Mehrzad, Dominic Yu, Richard J Aspinall, Matthew J Armstrong, Adrian Stanley, Hamish Ireland, Simon Travis, Peter Hayes, Mandy Lomax, Nicholas Roslund, Emily Lam, Gemma Slinn, Sue Jowett, Catherine Moakes, Alisha Maher, Elizabeth Brettell, Sukhwant Sehmi
INTRODUCTION: In liver cirrhosis, acute variceal bleeding (AVB) is associated with a 1-year mortality rate of up to 40%. Data on early or pre-emptive transjugular intrahepatic portosystemic stent-shunt (TIPSS) in AVB is inconclusive and may not reflect current management strategies. Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in AVB (REACT-AVB) aims to investigate the clinical and cost-effectiveness of early TIPSS in patients with cirrhosis and AVB after initial bleeding control...
March 22, 2024: BMJ Open Gastroenterology
https://read.qxmd.com/read/38518210/surgical-regret-and-intraoperative-decision-making-a-living-donor-kidney-case
#35
JOURNAL ARTICLE
Devon E Cassidy, Christian Vercler, Michael Englesbe, Janice Firn
Surgical regret often experienced at times of a great loss may cause a surgeon to reflect on their practice and intraoperative decision-making. It is inevitable that in the surgical profession, both in training and practice, a surgeon's decisions will be questioned by themselves, peers, and possibly patients. Here, we explore a case of living donor kidney donation in which the surgeon chooses to discontinue the operation for an incidental finding. Ultimately, this is against the patient's wishes and a decision over which both the surgeon and patient experience moral hazard and regret...
March 22, 2024: American Surgeon
https://read.qxmd.com/read/38516178/a-scoping-review-exploring-cure-definitions-and-language-for-inherited-hemoglobinopathies
#36
JOURNAL ARTICLE
Marilyn S Baffoe-Bonnie, K Jameson Floyd, Alicia A Livinski, Christine Grady
PURPOSE: Sickle cell disease and beta thalassemia are some of the first targets for potentially curative cell-based therapies. Currently, bone marrow transplants, stem cell transplants, and gene therapy are being researched and utilized for people living with these hemoglobinopathies. Although these therapies are often described as curative, there is not a clear definition of what cure means for these hemoglobinopathies. METHODS: Five databases were searched for this scoping review...
2024: Genet Med Open
https://read.qxmd.com/read/38514013/research-opportunities-and-ethical-considerations-for-heart-and-lung-xenotransplantation-research-a-report-from-the-national-heart-lung-and-blood-institute-workshop
#37
JOURNAL ARTICLE
Kiran K Khush, James L Bernat, Richard N Pierson, Henry J Silverman, Brendan Parent, Alexandra K Glazier, Andrew B Adams, Jay A Fishman, Michael Gusmano, Wayne J Hawthorne, Mary E Homan, Daniel J Hurst, Stephen Latham, Chung-Gyu Park, Karen J Maschke, Muhammad M Mohiuddin, Robert A Montgomery, Jonah Odim, Rebecca D Pentz, Bruno Reichart, Julian Savulescu, Paul Root Wolpe, Renee P Wong, Kathleen N Fenton
Xenotransplantation offers the potential to meet the critical need for heart and lung transplantation presently constrained by the current human donor organ supply. Much was learned over the past decades regarding gene editing to prevent the immune activation and inflammation that cause early organ injury, and strategies for maintenance of immunosuppression to promote longer-term xenograft survival. However, many scientific questions remain regarding further requirements for genetic modification of donor organs, appropriate contexts for xenotransplantation research (including nonhuman primates, recently deceased humans, and living human recipients), and risk of xenozoonotic disease transmission...
March 19, 2024: American Journal of Transplantation
https://read.qxmd.com/read/38501716/beyond-the-final-heartbeat-neurological-perspectives-on-normothermic-regional-perfusion-for-organ-donation-after-circulatory-death
#38
REVIEW
Matthew P Kirschen, Ariane Lewis, Michael A Rubin, Panayiotis N Varelas, David M Greer
Normothermic regional perfusion (NRP) has recently been used to augment organ donation after circulatory death (DCD) to improve the quantity and quality of transplantable organs. In DCD-NRP, after withdrawal of life-sustaining therapies and cardiopulmonary arrest, patients are cannulated onto extracorporeal membrane oxygenation to reestablish blood flow to targeted organs including the heart. During this process, aortic arch vessels are ligated to restrict cerebral blood flow. We review ethical challenges including whether the brain is sufficiently reperfused through collateral circulation to allow reemergence of consciousness or pain perception, whether resumption of cardiac activity nullifies the patient's prior death determination, and whether specific authorization for DCD-NRP is required...
March 19, 2024: Annals of Neurology
https://read.qxmd.com/read/38499505/developing-guidance-for-donor-intervention-randomized-controlled-trials-initial-discussions-from-the-canada-united-kingdom-2022-workshop
#39
JOURNAL ARTICLE
Marat Slessarev, Katie L Bain, John Basmaji, Tom D Blydt-Hansen, Jessie Cooper, Frédérick D'Aragon, Lorenzo Del Sorbo, Amy Evans, Anthony C Gordon, Gail Klein, Maureen O Meade, Nicholas Murphy, Helen L Thomas, Matthew J Weiss, Charles Weijer, Dan Harvey
BACKGROUND: Donor interventions, including medications, protocols, and medical devices administered to donors, can enhance transplantable organ quality and quantity and maximize transplantation success. However, there is paucity of high-quality evidence about their effectiveness, in part because of ethical, practical, and regulatory challenges, and lack of guidance about conduct of donor intervention randomized controlled trials (RCTs). METHODS: With the vision to develop authoritative guidance for conduct of donor intervention RCTs, we convened a workshop of Canadian-United Kingdom experts in organ donation and transplantation ethics, research, and policy to identify stakeholders, explore unique challenges, and develop research agenda to inform future work in this promising field...
March 19, 2024: Transplantation
https://read.qxmd.com/read/38492184/embodiment-and-regenerative-implants-a-proposal-for-entanglement
#40
JOURNAL ARTICLE
Manon van Daal, Anne-Floor J de Kanter, Karin R Jongsma, Annelien L Bredenoord, Nienke de Graeff
Regenerative Medicine promises to develop treatments to regrow healthy tissues and cure the physical body. One of the emerging developments within this field is regenerative implants, such as jawbone or heart valve implants, that can be broken down by the body and are gradually replaced with living tissue. Yet challenges for embodiment are to be expected, given that the implants are designed to integrate deeply into the tissue of the living body, so that implant and body become one. In this paper, we explore how regenerative implants may affect the embodied experience of implant recipients...
March 16, 2024: Medicine, Health Care, and Philosophy
keyword
keyword
46895
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.